Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Juergen Cox"'
Autor:
Stefka Tyanova, Reidar Albrechtsen, Pauliina Kronqvist, Juergen Cox, Matthias Mann, Tamar Geiger
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-11 (2016)
Breast cancers have been extensively studied at the genomic and transcriptomic levels in the hope of tailoring therapeutic regimens. Here the authors generate deep coverage proteomes from several clinical breast cancer samples, and use machine learni
Externí odkaz:
https://doaj.org/article/624efee6adce4116946c6179f2b085b2
Autor:
Nagarjuna Nagaraj, Jacek R Wisniewski, Tamar Geiger, Juergen Cox, Martin Kircher, Janet Kelso, Svante Pääbo, Matthias Mann
Publikováno v:
Molecular Systems Biology, Vol 7, Iss 1, Pp 1-8 (2011)
Abstract While the number and identity of proteins expressed in a single human cell type is currently unknown, this fundamental question can be addressed by advanced mass spectrometry (MS)‐based proteomics. Online liquid chromatography coupled to h
Externí odkaz:
https://doaj.org/article/11014317831e48fa8f4307c72bbdbcc4
Autor:
Emma Lundberg, Linn Fagerberg, Daniel Klevebring, Ivan Matic, Tamar Geiger, Juergen Cox, Cajsa Älgenäs, Joakim Lundeberg, Matthias Mann, Mathias Uhlen
Publikováno v:
Molecular Systems Biology, Vol 6, Iss 1, Pp 1-9 (2010)
Abstract An essential question in human biology is how cells and tissues differ in gene and protein expression and how these differences delineate specific biological function. Here, we have performed a global analysis of both mRNA and protein levels
Externí odkaz:
https://doaj.org/article/9b71e12be86c41308172823bdb8f9a2d
Publikováno v:
PLoS Genetics, Vol 6, Iss 9, p e1001090 (2010)
Along the transformation process, cells accumulate DNA aberrations, including mutations, translocations, amplifications, and deletions. Despite numerous studies, the overall effects of amplifications and deletions on the end point of gene expression-
Externí odkaz:
https://doaj.org/article/1d86fec0076944a792e8b7e7e62a4f01
Breast cancer is the second leading cause of cancer death for women in the United States. Of the different subtypes, estrogen receptor–negative (ER−) tumors, which are ErbB2+ or triple-negative, carry a relatively poor prognosis. In this study, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c369627e35c93573f2a10b3e615ceb
https://doi.org/10.1158/0008-5472.c.6503970
https://doi.org/10.1158/0008-5472.c.6503970
